4583-86-2

Basic information

• Product Name: 2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-1-methyl-(9CI)
• Synonyms: 2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-1-methyl-(9CI);5-methoxy-1-methyl-1H-benzo[d]imidazol-2(3H)-one
• CAS NO: 4583-86-2
• Molecular Formula: C₉H₁₀N₂O₂
• Molecular Weight: 178.19
• Product Categories: BENZIMIDAZOLE
• Mol File: 4583-86-2.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-1-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-1-methyl-(9CI)(4583-86-2)
• EPA Substance Registry System: 2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-1-methyl-(9CI)(4583-86-2)

Safety Data

• Hazardous Substances Data: 4583-86-2(Hazardous Substances Data)

Usage

General Description

2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-1-methyl-(9CI) is a chemical compound with a molecular formula C10H12N2O2. It is a derivative of benzimidazole and contains a 1,3-dihydro-5-methoxy-1-methyl group. 2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-1-methyl-(9CI) is primarily used in pharmaceutical research and has demonstrated potential biological activity in various studies. Its specific properties and potential uses are still being investigated, and further research is required to fully understand its potential applications in the medical and pharmaceutical fields.

Upstream product

• 129139-48-6 5-methoxy-N-methyl-1,2-phenylenediamine 
• 503-38-8 trichloromethyl chloroformate 
• 3360-78-9 4-methoxy-N-methyl-1,2-phenylenediamine 
• 530-62-1 1,1'-carbonyldiimidazole 

Downstream Products

• 79759-30-1 5-methoxy-1-methyl-3-phenyl-1,3-dihydro-2H-benzo[d]imidazol-2-one 

Relevant articles and documents

Iron-Catalyzed Intramolecular C—H Amidation of N-Benzoyloxyureas

A redox-neutral Fe-catalyzed intramolecular C—H amidation of N-benzoyloxyureas is described. This methodology employs a simple iron complex in situ generated from Fe(OTf)2 and bipyridine as the catalyst and N-benzoyloxyureas as the nitrene prec

THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS

The present invention relates to novel Thiazole Derivatives, compositions comprising the Thiazole Derivatives, and methods for using the Thiazole Derivatives for treating or preventing a proliferative disorder, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral infection, a fungal infection, or a disorder related to the activity of a protein kinase.

Medicament Combinations for the Treatment of Respiratory Diseases

The present invention relates to new medicament combinations which contain in addition to one or more, preferably one compound of general formula 1 wherein A, B, R1, X, n and m may have the meanings given in the claims and in the specification, at least one other active substance 2, processes for preparing them and their use as pharmaceutical compositions.